A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody | Alzheimer's Research and Therapy | 2021 | 92 |
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group | Lancet Neurology, The | 2021 | 86 |
Ovarian Hyperthecosis: Hyperandrogenism in a Post-Menopausal Woman | Journal of the Endocrine Society | 2021 | 78 |
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry | 2021 | 63 |
Aducanumab produced a clinically meaningful benefit in association with amyloid lowering | Alzheimer's Research and Therapy | 2021 | 57 |
Synthesis of Yttrium Superhydride Superconductor with a Transition Temperature up to 262 K by Catalytic Hydrogenation at High Pressures | Physical Review Letters | 2021 | 49 |
New approaches to symptomatic treatments for Alzheimer's disease | Molecular Neurodegeneration | 2021 | 35 |
Estimation of differential occupational risk of COVID-19 by comparing risk factors with case data by occupational group | American Journal of Industrial Medicine | 2021 | 29 |
Aducanumab: Appropriate Use Recommendations | journal of prevention of Alzheimer's disease, The | 2021 | 26 |
Developing the ATX(N) classification for use across the Alzheimer disease continuum | Nature Reviews Neurology | 2021 | 25 |
Microbial dark matter coming to light: challenges and opportunities | National Science Review | 2021 | 17 |
COVID-19 and Personality: A Cross-Sectional Multicenter Study of the Relationship Between Personality Factors and COVID-19-Related Impacts, Concerns, and Behaviors | Frontiers in Psychiatry | 2021 | 17 |
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis | Journal of Internal Medicine | 2021 | 15 |
Promoting Rigorous Research: Generalizability and Qualitative Research | Journal of Counseling and Development | 2021 | 14 |
WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1 | Journal of Extracellular Vesicles | 2021 | 14 |
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease. | Nature Aging | 2021 | 13 |
To dry perchance to live: Insights from the genome of the desiccation-tolerant biocrust moss Syntrichia caninervis | Plant Journal | 2021 | 13 |
Artificial nightlight alters the predator–prey dynamics of an apex carnivore | Ecography | 2021 | 13 |
Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease | Genome Research | 2021 | 13 |
Statewide Stay-at-Home Directives on the Spread of COVID-19 in Metropolitan and Nonmetropolitan Counties in the United States | Journal of Rural Health | 2021 | 12 |
The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases | American Journal of Geriatric Psychiatry | 2021 | 11 |
Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease | Neurology | 2021 | 11 |
Understanding Psychological Distress and Protective Factors Amongst Older Adults During the COVID-19 Pandemic | American Journal of Geriatric Psychiatry | 2021 | 11 |
Carbon-based adsorbents for fluoroquinolone removal from water and wastewater: A critical review | Environmental Research | 2021 | 10 |
Paraburkholderia youngii sp. nov. and 'Paraburkholderia atlantica' - Brazilian and Mexican Mimosa-associated rhizobia that were previously known as Paraburkholderia tuberum sv. mimosae | Systematic and Applied Microbiology | 2021 | 10 |